Esteban Felix/AP hide caption

toggle caption Esteban Felix/AP

Pfizer says its COVID-19 vaccine is shown to be extremely effective in young teenagers.

Esteban Felix/AP

Scientists are growing concerned the U.S. may be headed for a fourth wave. COVID-19 cases are rising rapidly, mirroring an increase in many countries around the world.

Harvard epidemiologist Bill Hanage tells NPR he's worried another surge in the U.S. will fuel the spread of the variant known as B.1.1.7 .

In the meantime, there's new evidence that vaccines from Pfizer and Moderna are effective at preventing viral spread — and that they produce "robust" antibody response in children ages 12-15. NPR's Joe Palca has more.

In participating regions, you'll also hear from local journalists about what's happening in your community.

Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..

This episode was produced by Brent Baughman, Brianna Scott and Lee Hale. It was edited by Sami Yenigun with help from Rob Stein and Wynne Davis. Our executive producer is Cara Tallo.

Northern California
Public Media Newsletter

Get the latest updates on programs and events.